![](/img/cover-not-exists.png)
CXCR4 mutational status does not impact outcomes in patients with Waldenstrom macroglobulinemia treated with proteasome inhibitors
Castillo, Jorge J., Gustine, Joshua N., Meid, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Jimenez, Cristina, Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, PattLanguage:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.25730
Date:
January, 2020
File:
PDF, 1.13 MB
english, 2020